YH Chen, LY Chau, JW Chen, SJ Lin - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—The distribution of numbers of (GT) n repeats was divided into two subclasses: class
S included shorter (<27) repeats, and class L included longer (≥27) repeats. Among those with
diabetes, subjects with the L/L genotype had significantly lower bilirubin levels than those ... Cited by 1 - Related articles - All 5 versions
- ►diabetesjournals.org [PDF] YH Chen, LY Chau, JW Chen, SJ Lin - Diabetes Care, 2008 - Am Diabetes Assoc 1 Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of
China; 2 Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of
China; 3 Cardiovascular Research Center, National Yang-Ming University, Taipei, ... Cited by 1 - Related articles - All 3 versions
PD MD - Am Diabetes Assoc 1Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of
China; 2Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of
China; 3Cardiovascular Research Center, National Yang-Ming University, Taipei, ... Related articles
M Yoshida, H Kimura, K Kyuki, M Ito - European journal of pharmacology, 2006 - Elsevier We investigated the effects of long-term treatment with probucol, a hypolipidemic agent with antioxidative
action, insulin, or their combination on renal damage in streptozotocin-induced diabetic rats fed
a high cholesterol diet. Increases in urinary albumin and lipid peroxide excretions were ... Cited by 4 - Related articles - All 5 versions
TC Wu, YH Chen, HB Leu, YL Chen, FY Lin, SJ Lin, … - Free Radical Biology and …, 2007 - Elsevier Matrix metalloproteinase (MMP) is critical to the progression of atherosclerosis and neointima
hyperplasia after vascular injury. We investigated the effects of carvedilol, a pharmacological
antioxidant with α- and β-adrenergic blocking activity, on MMP-2 and MMP-9 expression. ... Cited by 6 - Related articles - All 5 versions
MC Aubin, M Carrier, YF Shi, JC Tardif, LP … - Journal of …, 2006 - journals.lww.com The lipid-lowering agent probucol may be efficacious, through its antioxidant properties, to limit
and reverse the vascular endothelial dysfunction associated with left ventricular hypertrophy
(LVH). LVH was induced by performing an aortic banding (AB) on swine, except for ... Cited by 6 - Related articles - BL Direct - All 7 versions
GL Nunes, AC Abizaid, MP Theodoro, FS Brito, A … - American Heart Journal, 2006 - Elsevier Of the 59 randomized patients, 54 underwent successful stent implantation, completed the
follow-up period, and underwent repeat angiography, 6.1 ± 1.1 months after the procedure. Volumetric
IVUS analysis revealed similar intimal hyperplasia volumes (403 ± 26.7 mm3 for probucol ... Cited by 7 - Related articles - All 2 versions
MJ Sheetz, RL Bamhart, RL Jackson, KM Robinson - Metabolism, 1994 - grande.nal.usda.gov Record Detail. Return to previous page, Save: Title: MDL 29311, an analog of probucol, decreases
triglycerides in rats by increasing hepatic clearance of very-low-density lipoprotein. Author: Sheetz,
MJ : Barnhart, RL : Jackson, RL : Robinson, KM Citation: Metabolism. ... Cited by 8 - Related articles - Cached - BL Direct - All 3 versions
K Endo, Y Miyashita, H Sasaki, M Ohira, A Saiki, N … - Diabetes research and …, 2006 - Elsevier Probucol has antioxidant and cholesterol-lowering effects. This study examined the effect of probucol
on progression of diabetic nephropathy. We performed a randomized, open trial on 102 type
2 diabetes patients with clinical albuminuria (urinary albumin excretion >300 mg/g Cr). ... Cited by 9 - Related articles - All 8 versions
